Douglas R. Martin, MD, is the Life Sciences Global Portfolio Practice Leader. He has been a consultant to leading life sciences corporations and their investors since 1998.
Doug joined Guidehouse with the firm’s acquisition of Leerink Swann Consulting, which he co-founded, in 2014. His primary focus has been in product, disease, and therapeutic area strategy and due diligence on behalf of senior management and pipeline marketing and business/ corporate development teams. He has worked in virtually every therapeutic area and serves primarily biopharmaceutical clients and their investors.
Doug began his consulting career at McKinsey & Company. Prior to joining McKinsey, he completed his residency in Internal Medicine at Brigham and Women’s Hospital, served as a teaching fellow at Harvard Medical School, and was elected Chief Resident at the West Roxbury VA Hospital, one of the program’s two base hospitals.